• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨骼肌质量与内脏脂肪面积比值是影响非酒精性脂肪肝肝脏状况的重要决定因素。

Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease.

机构信息

Doctoral Programs in Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.

Japan Society for the Promotion of Science, Tokyo, Japan.

出版信息

J Gastroenterol. 2018 Apr;53(4):535-547. doi: 10.1007/s00535-017-1377-3. Epub 2017 Aug 8.

DOI:10.1007/s00535-017-1377-3
PMID:28791501
Abstract

BACKGROUND

Not only obesity but also sarcopenia is associated with NAFLD. The influence of altered body composition on the pathophysiology of NAFLD has not been fully elucidated. The aim of this study is to determine whether skeletal muscle mass to visceral fat area ratio (SV ratio) affects NAFLD pathophysiology.

METHODS

A total of 472 subjects were enrolled. The association between SV ratio and NAFLD pathophysiological factors was assessed in a cross-sectional nature by stratification analysis.

RESULTS

When the SV ratio was stratified by quartiles (Q -Q ), the SV ratio showed a negative relationship with the degree of body mass index, HOMA-IR, and liver stiffness (Q , 8.9 ± 7.5 kPa, mean ± standard deviation; Q , 7.5 ± 6.2; Q , 5.8 ± 3.7; Q , 5.0 ± 1.9) and steatosis (Q , 282 ± 57 dB/m; Q , 278 ± 58; Q , 253 ± 57; Q , 200 ± 42) measured by transient elastography. Levels of leptin and biochemical markers of liver cell damage, liver fibrosis, inflammation and oxidative stress, and hepatocyte apoptosis were significantly higher in subjects in Q than in those in Q , Q , or Q . Moreover, fat contents in femoral muscles were significantly higher in subjects in Q and the change was associated with weakened muscle strength. In logistic regression analysis, NAFLD subjects with the decreased SV ratio were likely to have an increased risk of moderate-to-severe steatosis and that of advanced fibrosis.

CONCLUSIONS

Decreased muscle mass coupled with increased visceral fat mass is closely associated with an increased risk for exacerbating NAFLD pathophysiology.

摘要

背景

不仅肥胖,而且肌肉减少症也与 NAFLD 相关。改变的身体成分对 NAFLD 病理生理学的影响尚未完全阐明。本研究旨在确定骨骼肌质量与内脏脂肪面积比(SV 比)是否影响 NAFLD 病理生理学。

方法

共纳入 472 例受试者。通过分层分析,从横断面角度评估 SV 比与 NAFLD 病理生理因素之间的关系。

结果

当 SV 比按四分位数(Q-Q)分层时,SV 比与体重指数、HOMA-IR 和肝脏硬度的程度呈负相关(Q1:8.9±7.5 kPa,平均值±标准差;Q2:7.5±6.2;Q3:5.8±3.7;Q4:5.0±1.9)和通过瞬态弹性成像测量的脂肪变性(Q1:282±57 dB/m;Q2:278±58;Q3:253±57;Q4:200±42)。Q1 组的瘦素水平和肝损伤、肝纤维化、炎症和氧化应激以及肝细胞凋亡的生化标志物明显高于 Q2、Q3 和 Q4 组。此外,Q1 组的股四头肌脂肪含量明显较高,且这种变化与肌肉力量减弱有关。在逻辑回归分析中,SV 比值降低的 NAFLD 患者发生中重度脂肪变性和进展性纤维化的风险增加。

结论

肌肉质量减少伴内脏脂肪质量增加与 NAFLD 病理生理学恶化的风险增加密切相关。

相似文献

1
Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease.骨骼肌质量与内脏脂肪面积比值是影响非酒精性脂肪肝肝脏状况的重要决定因素。
J Gastroenterol. 2018 Apr;53(4):535-547. doi: 10.1007/s00535-017-1377-3. Epub 2017 Aug 8.
2
Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Predicts Hepatic Morbidities.附肢骨骼肌质量与内脏脂肪面积比值预测肝脏疾病。
Gut Liver. 2024 May 15;18(3):509-519. doi: 10.5009/gnl230238. Epub 2023 Nov 28.
3
Progressive reduction in skeletal muscle mass to visceral fat area ratio is associated with a worsening of the hepatic conditions of non-alcoholic fatty liver disease.骨骼肌质量与内脏脂肪面积之比的逐渐降低与非酒精性脂肪性肝病肝脏状况的恶化有关。
Diabetes Metab Syndr Obes. 2019 Apr 15;12:495-503. doi: 10.2147/DMSO.S185705. eCollection 2019.
4
The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes.2 型糖尿病女性患者非酒精性脂肪肝与骨骼肌质量至内脏脂肪面积比值的关系。
BMC Endocr Disord. 2019 Jul 17;19(1):76. doi: 10.1186/s12902-019-0404-1.
5
Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).肌肉减少症与非酒精性脂肪性肝病中肥胖和胰岛素抵抗无关,与显著的肝纤维化相关:全国性调查(KNHANES 2008-2011)。
Hepatology. 2016 Mar;63(3):776-86. doi: 10.1002/hep.28376. Epub 2016 Jan 14.
6
Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.非酒精性脂肪性肝病在鹿特丹研究中的表现:肌肉质量、肌少症、脂肪质量和脂肪分布。
J Bone Miner Res. 2019 Jul;34(7):1254-1263. doi: 10.1002/jbmr.3713. Epub 2019 May 10.
7
Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.非酒精性脂肪性肝病患者的肥胖与非肥胖患者的生活方式预测因素:一项横断面研究。
Clin Nutr. 2018 Oct;37(5):1550-1557. doi: 10.1016/j.clnu.2017.08.018. Epub 2017 Aug 30.
8
Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.肌肉减少症是非酒精性脂肪性肝炎和显著纤维化的独立危险因素。
J Hepatol. 2017 Jan;66(1):123-131. doi: 10.1016/j.jhep.2016.08.019. Epub 2016 Sep 4.
9
The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes.2型糖尿病男性患者肝脏脂肪变性与骨骼肌质量指数之间的关系。
Endocr J. 2016 Oct 29;63(10):877-884. doi: 10.1507/endocrj.EJ16-0124. Epub 2016 Jul 9.
10
Relationship between body composition and the histology of non-alcoholic fatty liver disease: a cross-sectional study.身体成分与非酒精性脂肪性肝病组织学之间的关系:一项横断面研究。
BMC Gastroenterol. 2021 Apr 13;21(1):170. doi: 10.1186/s12876-021-01748-y.

引用本文的文献

1
Body muscle mass versus fat mass: gender-specific associations with NAFLD and liver fibrosis.身体肌肉量与脂肪量:与非酒精性脂肪性肝病及肝纤维化的性别特异性关联
Lipids Health Dis. 2025 Sep 9;24(1):278. doi: 10.1186/s12944-025-02694-4.
2
Markers of body fat, the mediating role of alanine aminotransferase, and their association with the risk of metabolic dysfunction-associated steatotic liver disease.体脂标志物、丙氨酸氨基转移酶的中介作用及其与代谢功能障碍相关脂肪性肝病风险的关联。
Eur J Pediatr. 2025 Aug 2;184(8):524. doi: 10.1007/s00431-025-06332-0.
3
Relationship Between Fat-to-Muscle Ratio and Nonalcoholic Fatty Liver Disease in Middle-Aged and Older Adults with Type 2 Diabetes: Cross-Sectional Study.

本文引用的文献

1
Sarcopenia: Prevalence and associated factors based on different suggested definitions in community-dwelling older adults.肌肉减少症:基于社区居住老年人不同建议定义的患病率及相关因素
Geriatr Gerontol Int. 2016 Mar;16 Suppl 1:110-22. doi: 10.1111/ggi.12723.
2
Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).肌肉减少症与非酒精性脂肪性肝病中肥胖和胰岛素抵抗无关,与显著的肝纤维化相关:全国性调查(KNHANES 2008-2011)。
Hepatology. 2016 Mar;63(3):776-86. doi: 10.1002/hep.28376. Epub 2016 Jan 14.
3
2型糖尿病中老年患者脂肪与肌肉比例和非酒精性脂肪性肝病的关系:横断面研究
Diabetes Metab Syndr Obes. 2025 Jun 30;18:2067-2076. doi: 10.2147/DMSO.S526335. eCollection 2025.
4
Beyond Traditional Body Composition Metrics: Load-Capacity Indices Emerge as Predictors of Cardiometabolic Outcomes-A Systematic Review and Meta-Analysis.超越传统身体成分指标:负荷能力指数成为心血管代谢结局的预测指标——一项系统评价与荟萃分析
Adv Nutr. 2025 Feb;16(2):100364. doi: 10.1016/j.advnut.2024.100364. Epub 2025 Jan 3.
5
Resting Heart Rate Variability is Independently Associated with Visceral Fat Rating Scores in Saudi Adult Males.静息心率变异性与沙特成年男性内脏脂肪评分独立相关。
Arq Bras Cardiol. 2024 Sep;121(5):e20220780. doi: 10.36660/abc.20220780.
6
Association of muscle mass, grip strength and fat-to-muscle ratio and metabolic dysfunction-associated steatotic liver disease in a middle-to-elderly aged population.在中老年人群中,肌肉质量、握力和脂肪-肌肉比与代谢功能障碍相关的脂肪性肝病的关系。
Ann Med. 2024 Dec;56(1):2390169. doi: 10.1080/07853890.2024.2390169. Epub 2024 Aug 12.
7
Association between the skeletal muscle mass to visceral fat area ratio and metabolic dysfunction-associated fatty liver disease: A cross-sectional study of NHANES 2017-2018.骨骼肌与内脏脂肪面积比值与代谢相关脂肪性肝病的关系:NHANES 2017-2018 的横断面研究。
J Diabetes. 2024 Jun;16(6):e13569. doi: 10.1111/1753-0407.13569.
8
Muscle Quality as a Potential Diagnostic Marker of Advanced Liver Fibrosis in Patients with Non-alcoholic Fatty Liver Disease.肌肉质量作为非酒精性脂肪性肝病患者晚期肝纤维化的潜在诊断标志物
J Obes Metab Syndr. 2024 Jun 30;33(2):143-154. doi: 10.7570/jomes23072. Epub 2024 May 13.
9
Influence of Sugar-Sweetened Beverages Intake on Sarcopenic Obesity, Visceral Obesity, and Sarcopenia in Lebanese Patients with MASLD: A Case-Control Study.含糖饮料摄入量对黎巴嫩非酒精性脂肪性肝病患者肌肉减少性肥胖、内脏肥胖和肌肉减少症的影响:一项病例对照研究
Healthcare (Basel). 2024 Mar 5;12(5):591. doi: 10.3390/healthcare12050591.
10
Body Composition in Chronic Liver Disease.慢性肝病中的身体成分。
Int J Mol Sci. 2024 Jan 12;25(2):964. doi: 10.3390/ijms25020964.
Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011).
肌肉减少症与非酒精性脂肪性肝病相关,与肥胖和胰岛素抵抗无关:全国性调查(KNHANES 2008-2011)。
J Hepatol. 2015 Aug;63(2):486-93. doi: 10.1016/j.jhep.2015.02.051. Epub 2015 Mar 12.
4
Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.肌肉减少症、肌肉内脂肪沉积和内脏肥胖独立预测肝细胞癌的结局。
J Hepatol. 2015 Jul;63(1):131-40. doi: 10.1016/j.jhep.2015.02.031. Epub 2015 Feb 24.
5
Acceleration training for managing nonalcoholic fatty liver disease: a pilot study.加速训练对非酒精性脂肪性肝病的管理:一项试点研究。
Ther Clin Risk Manag. 2014 Nov 7;10:925-36. doi: 10.2147/TCRM.S68322. eCollection 2014.
6
Moderate to vigorous physical activity volume is an important factor for managing nonalcoholic fatty liver disease: a retrospective study.中高强度体力活动量是管理非酒精性脂肪肝的一个重要因素:一项回顾性研究。
Hepatology. 2015 Apr;61(4):1205-15. doi: 10.1002/hep.27544. Epub 2015 Feb 17.
7
Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.骨骼肌消耗是肝细胞癌的一个独立预后因素。
J Gastroenterol. 2015 Mar;50(3):323-32. doi: 10.1007/s00535-014-0964-9. Epub 2014 May 10.
8
Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study.肌少症与非酒精性脂肪肝的关系:韩国肌少性肥胖研究。
Hepatology. 2014 May;59(5):1772-8. doi: 10.1002/hep.26716. Epub 2014 Mar 24.
9
Impact of sarcopenia on survival in patients undergoing living donor liver transplantation.肌肉减少症对活体供肝移植患者生存的影响。
Am J Transplant. 2013 Jun;13(6):1549-56. doi: 10.1111/ajt.12221. Epub 2013 Apr 19.
10
Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance.胎球蛋白-A 作为 TLR4 的内源性配体,促进脂类诱导的胰岛素抵抗。
Nat Med. 2012 Aug;18(8):1279-85. doi: 10.1038/nm.2851. Epub 2012 Jul 29.